SearchDictionaryMobileLogin

[Non necrotizing bacterial cellulitis and bacteriemia due to Shewanella putrefaciens]

AbstractShewanella putrefaciens is a Gram negative opportunistic pathogen which causes skin and soft tissue infections and bacteriemia in immunocompromized patients. We report a 86-year-old man, who presented with an infectious cellulitis of the leg associated with Shewanella putrefaciens bacteriemia. This patient was treated by mycophenolate mofetil for a bullous pemphigoid resistant to corticotherapy.
AuthorsT Aubert, C Rovery, K Bourhaba, S Singeorzan, M Heim, E Crétel (Affiliation: Service de gériatrie sud, hôpital Sainte-Marguerite, 270, boulevard de Sainte-Marguerite, BP 29, 13274 Marseille cedex 09, France.)
JournalLa Revue de médecine interne / fondée ... par la Société nationale francaise de médecine interne (Rev Med Interne) Vol. 30 Issue 9 Pg. 800-2 (Sep 2009) ISSN: 0248-8663 [Print] France
Vernacular TitleDermohypodermite bactérienne non nécrosante et bactériémie à Shewanella putrefaciens.
PMID19282070 (Publication Type: Case Reports, Comparative Study, English Abstract, Journal Article)
Chemical References
  • Anti-Bacterial Agents
  • Anti-Infective Agents
  • Dermatologic Agents
  • mycophenolate mofetil
  • Mycophenolic Acid
  • Ceftriaxone
  • Ciprofloxacin
Topics
  • Aged, 80 and over
  • Anti-Bacterial Agents (administration & dosage, therapeutic use)
  • Anti-Infective Agents (administration & dosage, therapeutic use)
  • Bacteremia (drug therapy, microbiology)
  • Ceftriaxone (administration & dosage, therapeutic use)
  • Cellulitis (drug therapy, microbiology)
  • Ciprofloxacin (administration & dosage, therapeutic use)
  • Dermatologic Agents (administration & dosage, therapeutic use)
  • Drug Therapy, Combination
  • Follow-Up Studies
  • Gram-Negative Bacterial Infections (drug therapy)
  • Humans
  • Immunocompromised Host
  • Male
  • Mycophenolic Acid (analogs & derivatives, therapeutic use)
  • Pemphigoid, Bullous (drug therapy)
  • Shewanella putrefaciens
  • Time Factors
  • Treatment Outcome